Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Atia Vision logo — company profile

Atia Vision

Founded 2012 United States Campbell, United States 34 employees Venture round Total: $111.09M Biotechnology, Health Care +1

General Information

Company Name Atia Vision
Founded Year 2012
Location United States Campbell, United States
Employees 34
Industries Biotechnology, Health Care, Medical Devices
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Atia Vision. To contact Atia Vision, visit atiavision.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Atia Vision compare?

A PDF of Atia Vision and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Atia Vision soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Atia Vision

Atia Vision is a portfolio company of Shifamed, LLC, a highly-specialized medical innovation hub focused on developing advanced solutions that get to market faster, reduce risk, increase impact, and forge a path toward a world where all people are able to lead longer, healthier lives. Founded in 2012 and headquartered in the United States, the company is committed to improving patient outcomes by developing a safe and controllable presbyopia correcting IOL that aims to restore the full range of functional vision in cataract patients, the largest segment of the ophthalmology market.

Atia Vision’s OmniVu™ Modular Shape-Changing Intraocular Lens (IOL) is an investigational device and it is not approved for sale or use in the United States. The company recently secured a $28.65M Venture Round investment on 22 August 2022.

The company operates in the Biotechnology and Health Care industries, positioning itself at the forefront of medical innovation and offering promising prospects for the future of ophthalmic healthcare.

Business keywords: medical innovation, ophthalmology, presbyopia, cataract surgery, intraocular lens, vision correction, innovation hub, patient outcomes, surgical solutions

Funding Rounds & Investors (8)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round $28.65M -
22 Aug 2022
Series E $42.00M 4
The Capital Partnership Cormorant Asset Management AMED Ventures
The Capital Partnership, Cormorant Asset Management +2
02 Aug 2022
Venture Round $5.44M -
22 Nov 2021
Debt Financing Undisclosed -
22 Nov 2021
Series D $20.00M 4
ShangBay Capital The Capital Partnership Cormorant Asset Management
ShangBay Capital, The Capital Partnership +2
02 May 2019
Series C $10.00M 3
The Capital Partnership Cormorant Asset Management
The Capital Partnership, Cormorant Asset Management +1
10 Dec 2018
Venture Round $2.00M -
30 Mar 2018
Series B $3.00M 3
Rising Tide Delos Capital
Rising Tide, Delos Capital +1
12 May 2015

Atia Vision Alternatives & Competitors

View All Alternatives
Atia Vision vs
PowerVision, Inc.
PowerVision, Inc. United States

Restoring True Vision for All Distances

Series D
13 employees
Biotechnology, Health Care
Compare Atia Vision vs PowerVision, Inc.
Atia Vision vs
LensGen, Inc.
LensGen, Inc. United States

Restoring Youthful Vision

Venture round
12 employees
Health Care, Medical Devices
Atia Vision vs
Adaptilens
Adaptilens United States

The first biomimetic accommodating IOL

Series A
9 employees
Health Care, Medical Devices
Compare Atia Vision vs Adaptilens
View all alternatives

FAQ About Atia Vision

Atia Vision is a portfolio company of Shifamed, LLC, a highly-specialized medical innovation hub focused on developing advanced solutions that get to market faster, reduce risk, increase impact, and forge a path toward a world where all people are able to lead longer, healthier lives. Disclaimer:...
Atia Vision was founded in 2012.
Atia Vision is headquartered in Campbell, United States.
Atia Vision operates in Biotechnology, Health Care and Medical Devices. Its work centres on medical innovation, ophthalmology, presbyopia and cataract surgery.
Atia Vision has approximately 34 employees.
Atia Vision has completed 8 funding rounds, raising a total of $111.09M. The latest funding stage is Venture round.
Top alternatives and competitors to Atia Vision include PowerVision, Inc., LensGen, Inc., Adaptilens, EYE PCR BV, IQ Medical Pty Ltd. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Atia Vision and PowerVision, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Atia Vision, https://bouncewatch.com/company/atia-vision, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes